Overview

Specified Drug Use-Results Survey of Regnite

Status:
Completed

Trial end date:
2019-02-28

Target enrollment:

Participant gender:

Summary

This study is to investigate the long-term safety and efficacy and the information on the proper use of Regnite® under conditions of daily clinical use.

Details

Lead Sponsor:

Astellas Pharma Inc

Treatments:

Gabapentin